Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be tested is OpRegen, which the company indicates is “the first IND for an ES cell-based […]
BioTime Cell Cure Files IND with FDA for ES cell AMD therapy Read More »
In a major first for the stem cell and regenerative medicine fields, a patient in Japan today received a pioneering transplant of a retinal pigmented epithelial (RPE) sheet made from induced pluripotent stem (iPS) cells, also known by the acronym IPSC. This is the first ever iPS cell-based transplant into a human. The patient is
Landmark: patient receives first ever iPS cell based transplant Read More »
Below is a list of upcoming stem cell and regenerative medicine conferences and meetings in 2015. If you do not see your meeting, please let me know and I will include it. This list is meant to be as inclusive as possible, but by listing specific events I am not necessarily endorsing them. Enjoy! January
Stem Cell Meetings & Conferences 2015 Read More »
StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought
Interview with StemCells Inc. leadership on hot topics Read More »
This is a guest post on NIST. By Jeanne Loring Last week I visited NIST, the National Institute for Standards and Technologies in Gaithersburg, Maryland as a member of a review panel. NIST is the science branch of the US Department of Commerce, which is the business part of the government, and is not officially
The Measurers Size Up Stem Cells: what is NIST? Read More »
An international team of stem cell scientists has replicated human therapeutic cloning to make embryonic stem cells via somatic cell nuclear transfer (SCNT). The team was led by Drs. Dong Ryul Lee of CHA Stem Cell Institute in Korea and Robert Lanza of Advanced Cell Technology (ACT). They reported the advance in the Chung, et
Adult human therapeutic cloning of embryonic stem cells by SCNT Read More »
Turns out the show on stem cells that I and some others in the stem cell field will be on with Stephen Hawking that is airing next Monday, February 3rd, on the Science Channel is called “Stem Cell Universe with Stephen Hawking” (scroll down in this linked page to near the bottom as of Jan. 29
Stem Cell Universe with Stephen Hawking: TV show graphic and link Read More »
In the summer of 2013, the producer and crew of the Discovery Channel’s Through the Wormhole filmed two times at my house for a special episode on stem cells. I think it’s going to be a great show. The stem cell episode will first air on the Science/Discovery Channel on Feb. 3 (check your local listings
Exciting Being on Upcoming ‘Through the Wormhole’ Stem Cells Episode Read More »
The below is an excerpt from my book, Stem Cells: An Insider’s Guide. I hope you enjoy this excerpt and the book, which I think is a really good deal at under $27 paperback or under $17 for E-book version. Having our innovation and ethics too In the stem cell field you can have it
Book Excerpt: Stem Cell For-Profit Good Citizen Biotechs Read More »
In the interview below I talk with Dr. Masayo Takahashi, who is leading a team conducting the first ever in-human clinical study based on iPS cells. The work began with patient enrollment on Aug. 1, 2013 in Japan. Masaya Takahashi background 1. Can you tell us a bit about your background? As an M.D./Ph.D. and
Masayo Takahashi Interview on iPS cells, clinical studies, & more Read More »